|

Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Tang-Du Hospital1

Indications

  • Neoadjuvent1
  • PD-1 Inhibitor1
  • Esophageal Squamous Cell Carcinoma1
  • Chemotherapy1
  • Cancer1

Other1 trial

Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.